Malcolm Hill
Direktor/Vorstandsmitglied bei EVOKE PHARMA, INC.
Vermögen: 699 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Malcolm Hill
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 9 | |
Meritage Pharma, Inc.
 Meritage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Meritage Pharma, Inc. develops prescription products for the treatment of gastrointestinal and atopic diseases. The company was founded by Cam L. Garner, Elaine M. Phillips and Adam K. Simpson in March 2008 and is headquartered in San Diego, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Pvp Biologics, Inc.
 Pvp Biologics, Inc. Pharmaceuticals: MajorHealth Technology Pvp Biologics, Inc. engages in the development of therapeutic products. The company was founded by Ingrid Swanson Pultz, David Baker, and Justin Siegel in 2012 and is headquartered in San Diego, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Malcolm Hill
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Founder Director of Finance/CFO Director of Finance/CFO | |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Founder Founder Director/Board Member | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Investment Managers | Corporate Officer/Principal Chief Investment Officer | |
| QUIDELORTHO CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
SkinMedica, Inc.
 SkinMedica, Inc. Medical DistributorsDistribution Services SkinMedica, Inc. is a specialty skin care pharmaceutical company. It develops, acquires, and commercializes products for treatment of dermatologic conditions and improvement of skin appearance. It markets and sells to physicians, with a focus on aesthetics, both prescriptions and non-prescription skin care products. SkinMedica was founded in May 1999. Its company headquarters are located in Carlsbad, California. Company already EXT. Filed in HOL tracker. | Medical Distributors | Director/Board Member Founder | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
Aegis Therapeutics LLC
 Aegis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Aegis Therapeutics LLC manufactures pharmaceutical products. Its intravail drug delivery technology facilitates non-invasive delivery of protein and peptide drugs through injection. The company was founded by Edward T. Maggio and Ralph R. Barry and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Xcel Pharmaceuticals, Inc.
 Xcel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA | Pharmaceuticals: Major | Founder Founder | |
| University of Kentucky | College/University | Undergraduate Degree | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
| Virginia Commonwealth University | College/University | Doctorate Degree | |
| Duke University Graduate School | College/University | Doctorate Degree | |
Cantex Pharmaceuticals, Inc.
 Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
| Southeast BIO | Corporate Officer/Principal | ||
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OUTLOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
ADERIS Pharmaceuticals, Inc.
 ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Propharmacon LLC
 Propharmacon LLC Miscellaneous Commercial ServicesCommercial Services Propharmacon LLC operates a pharmaceutical consultant. Its services include technical writing, advertising and promotional reviews, quality systems, and audits. The company was founded in 2001 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree | |
CardioPolymers, Inc.
 CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Phenome Sciences, Inc. | Chief Executive Officer | ||
| Dorado Ventures LLC | President |
Statistik
International
| Vereinigte Staaten | 47 |
| Kanada | 3 |
| Vereinigtes Königreich | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 72 |
| Founder | 43 |
| Chairman | 26 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Cam Garner | 28 |
| Scott Glenn | 28 |
| Kenneth Widder | 24 |
| Todd Brady | 20 |
| Ann Rhoads | 19 |
| Richard Vincent | 13 |
| Marilyn Carlson | 12 |
| Adam Simpson | 10 |
| Elaine M. Phillips | 9 |
| David Gonyer | 8 |
| Matthew D'Onofrio | 6 |
| Vickie Reed | 6 |
- Börse
- Insiders
- Malcolm Hill
- Unternehmensverbindungen
